ARCHIVES
VOL. 3, ISSUE 2 (2021)
Impact of patient tailored clinical pharmacist intervention on inr in patients with anticoagulant and antipatelet therapy
Authors
Syama Priya Thampi, Susan Philip, Nalule Samalie, Gayatri Suresh, Raju Koneri
Abstract
In this study we sought to define, describe and categorise the nature of clinical pharmacist-initiated interventions performed and have explored the effects magnitude and rate of acceptance of interventions. Pharmacists are effective at recognizing potential and actual drug-related problems, such as drug-induced conditions and clinically relevant drug interactions. The participation of clinical pharmacist in providing interventions contributes to the optimisation of pharmacotherapy, in terms of choosing the most appropriate drug and/or the suitable dosage and may improve patient care. Here the clinical pharmacists performed the interventions on patient safety. These types of intervention is defined as any intervention that directly affects the wellbeing of the patients under antiplatelet and anticoagulant therapy. Risk of bleeding (GI bleeds) on triple therapy can be reduced with dosing adjustments and gastro protective therapy. Concomitant use of antiplatelet drugs appeared to increase the risk for major bleeding. Dosing of antithrombotic should be kept as low as possible Aspirin daily dose should be between 75 TO 100mg and acitrom 2mg.The INR should be titrated to the lowest possible dose. Target INR should be titrated between 2 to 2.5.This can lead to a significant reduction in bleeding events when patients treated with triple therapy. Target INR was achieved in 71% of the patient population. The use of Warfarin with dual antiplatelet represents a medical decision making challenge because it reduces the risks of thrombotic events together with an increased risk for bleeding.
Download
Pages:03-05
How to cite this article:
Syama Priya Thampi, Susan Philip, Nalule Samalie, Gayatri Suresh, Raju Koneri "Impact of patient tailored clinical pharmacist intervention on inr in patients with anticoagulant and antipatelet therapy ". International Journal of Medical Science and Research, Vol 3, Issue 2, 2021, Pages 03-05
Download Author Certificate
Please enter the email address corresponding to this article submission to download your certificate.